These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 29286135)

  • 61. Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor.
    Nicholls BM; Bredius RG; Hamdy NA; Gerritsen EJ; Lankester AC; Hogendoorn PC; Nesbitt SA; Horton MA; Flanagan AM
    J Bone Miner Res; 2005 Dec; 20(12):2264-70. PubMed ID: 16294279
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationship between fluoride exposure and osteoclast markers during RANKL-induced osteoclast differentiation.
    Junrui P; Bingyun L; Yanhui G; Xu J; Darko GM; Dianjun S
    Environ Toxicol Pharmacol; 2016 Sep; 46():241-245. PubMed ID: 27500448
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo.
    Okamoto M; Hiura K; Ohe G; Ohba Y; Terai K; Oshikawa T; Furuichi S; Nishikawa H; Moriyama K; Yoshida H; Sato M
    Cancer; 2000 Nov; 89(9):1966-75. PubMed ID: 11064354
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cellular and hormonal mechanisms associated with malignant bone resorption.
    Quinn JM; Matsumura Y; Tarin D; McGee JO; Athanasou NA
    Lab Invest; 1994 Oct; 71(4):465-71. PubMed ID: 7526033
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.
    Goto H; Hozumi A; Osaki M; Fukushima T; Sakamoto K; Yonekura A; Tomita M; Furukawa K; Shindo H; Baba H
    Cytokine; 2011 Dec; 56(3):662-8. PubMed ID: 21963155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
    Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
    Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
    Miyazaki M; Fujikawa Y; Takita C; Tsumura H
    Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of cells cultured from human giant-cell tumors of bone. Phenotypic relationship to the monocyte-macrophage and osteoclast.
    Komiya S; Sasaguri Y; Inoue A; Nakashima M; Yamamoto S; Yanagida I; Morimatsu M
    Clin Orthop Relat Res; 1990 Sep; (258):304-9. PubMed ID: 2168302
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancer-associated fibroblasts promote bone invasion in oral squamous cell carcinoma.
    Elmusrati AA; Pilborough AE; Khurram SA; Lambert DW
    Br J Cancer; 2017 Sep; 117(6):867-875. PubMed ID: 28742795
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.
    Choy J; Albers CE; Siebenrock KA; Dolder S; Hofstetter W; Klenke FM
    Bone; 2014 Dec; 69():80-8. PubMed ID: 25245204
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ; Athanasou NA
    J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
    Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
    Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
    J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines.
    Toyosaki-Maeda T; Takano H; Tomita T; Tsuruta Y; Maeda-Tanimura M; Shimaoka Y; Takahashi T; Itoh T; Suzuki R; Ochi T
    Arthritis Res; 2001; 3(5):306-10. PubMed ID: 11549372
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of OPG and RANKL expressed by human dental follicle cells in osteoclastogenesis.
    Sun H; Li Q; Zhang Y; Bi Y; Li X; Shu Y; Chen X; Jin Z; Ge C
    Cell Tissue Res; 2015 Nov; 362(2):399-405. PubMed ID: 26149648
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.
    Cafiero C; Gigante M; Brunetti G; Simone S; Chaoul N; Oranger A; Ranieri E; Colucci S; Pertosa GB; Grano M; Gesualdo L
    Nephrol Dial Transplant; 2018 Jan; 33(1):65-75. PubMed ID: 28992140
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bone invasion by oral squamous cell carcinoma: Molecular alterations leading to osteoclastogenesis - a review of literature.
    Vaassen LAA; Speel EM; Kessler PAWH
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1464-1471. PubMed ID: 28756966
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro.
    Xu F; Ye YP; Dong YH; Guo FJ; Chen AM; Huang SL
    J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):244-249. PubMed ID: 23592138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.